The FDA announced on May 20, 2025, that Becton Dickinson & Co. is voluntarily recalling the BD BACTEC MGIT 960 PZA Kit due to intermittent false resistance results for pyrazinamide during susceptibility testing of Mycobacterium tuberculosis isolates.
How to tell if you have it
- Brand: Becton Dickinson
- Product: BD BACTEC MGIT 960 PZA Kit
- Catalog No.: 245128
- UDI-DI: (01) 0038290245128
- Lot Nos.: 4150998, 4177908, 4178500, 4262031, 4262036, 4262037, 4262039, 4262040, 4262044, 4284438, 4284441, 4284443, 4284445, 4284449, 4304789, 4304796, 4347228, 4347230, 4352110, 4362418, 5007456, 5020153, 5050670, 5050671, 5050672, 5050675, 5050678
- Units affected: 12,256 eaches
The hazard
The FDA stated that Becton Dickinson has received additional complaints of intermittent false resistance results for pyrazinamide during susceptibility testing of Mycobacterium tuberculosis isolates.
Context
GovInfoNow's records show Becton Dickinson & Co. has 43 other recalls on record since June 1, 2017. Other recent recalls include the BD GasP: CO2 Pouch System Recall (April 7, 2026), the BD Kiestra Isolate Suspension Cuvette Array Recall (Oct. 23, 2025), and the BD BACTEC Blood Culture System Recall (Sept. 23, 2025). Other recent recalls of similar products include the Biomerieux VITEK 2 AST-N461 Test Kit Recall (July 24, 2026), the Biomerieux VITEK 2 AST-N447 Kit Recall (June 4, 2026), and the HardyDisk AST Cefiderocol 30μg FDC30 Recall (June 8, 2026).